CL2023002187A1 - Virus para vacuna contra el síndrome respiratorio y reproductivo porcino - Google Patents

Virus para vacuna contra el síndrome respiratorio y reproductivo porcino

Info

Publication number
CL2023002187A1
CL2023002187A1 CL2023002187A CL2023002187A CL2023002187A1 CL 2023002187 A1 CL2023002187 A1 CL 2023002187A1 CL 2023002187 A CL2023002187 A CL 2023002187A CL 2023002187 A CL2023002187 A CL 2023002187A CL 2023002187 A1 CL2023002187 A1 CL 2023002187A1
Authority
CL
Chile
Prior art keywords
viruses
respiratory syndrome
porcine reproductive
virus
vaccine against
Prior art date
Application number
CL2023002187A
Other languages
English (en)
Inventor
Qitu Wu Stephen
Prieto Suarez Cinta
Gregory Labarque Geoffrey
Original Assignee
Elanco Us Inc
Elanco Uk Ah Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Us Inc, Elanco Uk Ah Ltd filed Critical Elanco Us Inc
Publication of CL2023002187A1 publication Critical patent/CL2023002187A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a virus de síndrome respiratorio y reproductivo porcino, vivos modificados. Los virus se analizaron genéticamente y se seleccionaron en función de agrupaciones filogenéticas para su modificación mediante pases repetidos en cultivo tisular. Se evalúo la capacidad de los virus vivos modificados para proporcionar inmunidad protectora frente a virus heterólogos. Los virus vivos modificados son útiles en vacunas, particularmente en vacunas que pueden tratar la infección de cerdos por múltiples virus heterólogos.
CL2023002187A 2019-08-29 2023-07-25 Virus para vacuna contra el síndrome respiratorio y reproductivo porcino CL2023002187A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19382734 2019-08-29

Publications (1)

Publication Number Publication Date
CL2023002187A1 true CL2023002187A1 (es) 2023-12-15

Family

ID=67902445

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2021003447A CL2021003447A1 (es) 2019-08-29 2021-12-22 Virus para vacuna contra el síndrome respiratorio y reproductivo porcino
CL2023002187A CL2023002187A1 (es) 2019-08-29 2023-07-25 Virus para vacuna contra el síndrome respiratorio y reproductivo porcino

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2021003447A CL2021003447A1 (es) 2019-08-29 2021-12-22 Virus para vacuna contra el síndrome respiratorio y reproductivo porcino

Country Status (11)

Country Link
US (1) US20220241393A1 (es)
EP (1) EP4021577A1 (es)
JP (1) JP2022551368A (es)
KR (1) KR20220106679A (es)
CN (1) CN114502240A (es)
AU (1) AU2019463018A1 (es)
BR (1) BR112021026502A2 (es)
CA (1) CA3144160A1 (es)
CL (2) CL2021003447A1 (es)
MX (1) MX2021015938A (es)
WO (1) WO2021037387A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024077281A2 (en) * 2022-10-06 2024-04-11 Cornell University Genotyping and sequencing assays for prrsv

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7132106B2 (en) * 1998-12-22 2006-11-07 Pfizer Inc. Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
CA2650236C (en) * 1999-04-22 2016-01-12 United States Of America, As Represented By The Secretary Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
HUP0303431A2 (hu) * 2001-03-09 2004-01-28 Boehringer Ingelheim Vetmedica Gmbh PRRS vírus élő legyengített törzsei
DK2558118T3 (da) * 2010-04-16 2019-08-26 Univ Gent Krydsbeskyttende vaccine mod reproduktions- og respirationssyndromvirus hos svin
WO2013017568A1 (en) * 2011-07-29 2013-02-07 Boehringer Ingelheim Vetmedica Gmbh INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
ES2940691T3 (es) * 2013-12-20 2023-05-10 Boehringer Ingelheim Vetmedica Gmbh Variante de virus PRRS, clon de ADNc de virus PRRS europeo y usos de los mismos
ES2872500T3 (es) * 2014-07-21 2021-11-02 Fatro Spa Cepa atenuada del PRRS y uso potencial en preparados inmunizantes
TWI652347B (zh) * 2016-02-18 2019-03-01 美商益農美國公司 豬繁殖與呼吸綜合症疫苗病毒
RU2755345C2 (ru) * 2016-12-14 2021-09-15 Зоэтис Сервисиз Ллс Эффективная вакцинация против европейских штаммов вируса репродуктивного и респираторного синдрома (prrs) до отлучения от матери

Also Published As

Publication number Publication date
US20220241393A1 (en) 2022-08-04
CN114502240A (zh) 2022-05-13
MX2021015938A (es) 2022-04-26
WO2021037387A1 (en) 2021-03-04
BR112021026502A2 (pt) 2022-03-15
JP2022551368A (ja) 2022-12-09
AU2019463018A1 (en) 2022-02-03
CL2021003447A1 (es) 2022-08-05
EP4021577A1 (en) 2022-07-06
CA3144160A1 (en) 2021-03-04
KR20220106679A (ko) 2022-07-29

Similar Documents

Publication Publication Date Title
PH12018501750A1 (en) Porcine reproductive and respiratory syndrome vaccine virus
CO2019011548A2 (es) Vacunas contra el gallid herpesvirus 3 recombinante que codifican antígenos patogénicos aviares heterólogos
MX347210B (es) Vacunas combinadas para prevención de infecciones por virus porcino.
CL2023002187A1 (es) Virus para vacuna contra el síndrome respiratorio y reproductivo porcino
PE20140871A1 (es) COMPOSICIONES Y METODOS DE VACUNA DEL VIRUS TIPO 1b DE DIARREA VIRAL BOVINA
CO7461133A2 (es) Parvovirus 5a porcino, métodos de uso y vacuna
CO2022014152A2 (es) Vacuna contra el virus de la peste porcina africana
CO6361948A2 (es) Uso de antigeno de mycoplasma bovis
AR080313A1 (es) Composiciones de virus de moquillo canino (cdv) recombinante y sus usos
ME01140B (me) Virus goveđe virusne dijareje s modifikovanim erns proteinom
MX2018015506A (es) Vacuna contra virus de bronquitis infecciosa.
BR112019012158A2 (pt) vacinação eficaz contra cepas europeias de vírus da síndrome reprodutiva e respiratória suína (prrs) antes do desmame
CO7461135A2 (es) Parvovirus porcino 5b, métodos de uso y vacuna
CO6280408A2 (es) Vacuna de virus de la lengua azul y composiciones inmunogenicas procedimientos de uso y procedimeintos de la produccuion de la misma
NZ743977A (en) M hyo multivalent vaccine and uses thereof
TR201819340T4 (tr) IB-QX Benzeri Suşlardan Türetilmiş Enfeksiyöz Bronşit Aşıları
BR112022020298A2 (pt) Vacinas, adjuvantes e métodos para gerar uma resposta imune
BR112016012393A2 (pt) Vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado
BR112022019207A2 (pt) Composições de vacina para coronavírus e métodos de uso das mesmas
CL2020002876A1 (es) Vacuna contra la bronquitis infecciosa (divisional de la solicitud no. 201803420)
AR085800A1 (es) Vacuna de rinitis equina
UY38933A (es) Vacuna de partículas tipo virus del chicunguña y métodos para su uso
AR109291A1 (es) Clon de adnc del virus del síndrome reproductivo y respiratorio porcino y usos del mismo
BR112017004703A2 (pt) ?vacina e método para proteção de progênie de uma porca contra infeccção por um vírus de diarreia endêmica suína?
BR112012022680A2 (pt) métodos para proteger um animal um canino contra doença, e, uso de uma vacina contra vírus da influenza canina